Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Remme

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
European Journal of Heart Failure|May 30, 2002
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMETPhilip A Poole-Wilson, John G F Cleland, Andrea Di Lenarda, et al.
Annals of Tropical Medicine and Parasitology|June 26, 2002
Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC)M Noma, B E B Nwoke, I Nutall, et al.
Cardiovascular Drugs and Therapy|April 1, 1994
Acute systemic and antiischemic effects of epanolol in patients with coronary artery diseaseE H Venneker, W J Remme, D C van Hoogenhuyze, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectorisP J Bernink, P de Weerd, C F ten, et al.
The American Journal of Cardiology|December 15, 1991
Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery diseaseD Van Hoogenhuyze, N Weinstein, G J Martin, et al.
The American Journal of Cardiology|December 1, 1986
Temporal relation of changes in regional coronary flow and myocardial lactate and nucleoside metabolism during pacing-induced ischemiaW J Remme, R van den Berg, M Mantel, et al.
Atherosclerosis|October 28, 2008
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT studyClaudio Ceconi, Kim M Fox, William J Remme, et al.
Cardiovascular Drugs and Therapy|May 1, 1996
Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failureW J Remme, M van der Ent, G L Bartels, et al.
Journal of the American College of Cardiology|April 1, 1986
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarctionP W Serruys, M L Simoons, H Suryapranata, et al.
European Journal of Heart Failure|June 9, 2004
Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)Michel Komajda, Beatrix Lutiger, Hugo Madeira, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
European Journal of Heart Failure|May 30, 2002
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMETPhilip A Poole-Wilson, John G F Cleland, Andrea Di Lenarda, et al.
Annals of Tropical Medicine and Parasitology|June 26, 2002
Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC)M Noma, B E B Nwoke, I Nutall, et al.
Cardiovascular Drugs and Therapy|April 1, 1994
Acute systemic and antiischemic effects of epanolol in patients with coronary artery diseaseE H Venneker, W J Remme, D C van Hoogenhuyze, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectorisP J Bernink, P de Weerd, C F ten, et al.
The American Journal of Cardiology|December 15, 1991
Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery diseaseD Van Hoogenhuyze, N Weinstein, G J Martin, et al.
The American Journal of Cardiology|December 1, 1986
Temporal relation of changes in regional coronary flow and myocardial lactate and nucleoside metabolism during pacing-induced ischemiaW J Remme, R van den Berg, M Mantel, et al.
Atherosclerosis|October 28, 2008
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: results from the PERTINENT studyClaudio Ceconi, Kim M Fox, William J Remme, et al.
Cardiovascular Drugs and Therapy|May 1, 1996
Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failureW J Remme, M van der Ent, G L Bartels, et al.
Journal of the American College of Cardiology|April 1, 1986
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarctionP W Serruys, M L Simoons, H Suryapranata, et al.
European Journal of Heart Failure|June 9, 2004
Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN)Michel Komajda, Beatrix Lutiger, Hugo Madeira, et al.
Pageof 24